Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
2.
Intern Med J ; 42(7): 760-4, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22150918

ABSTRACT

BACKGROUND/AIM: Although thiazide-type diuretics can promote a positive calcium balance, thiazide can be associated with hyponatraemia, which is recently linked with heightened fracture risk. We examine the chance of developing fracture in patients with and without hyponatraemia after taking thiazide diuretics. METHODS: In this single-centre retrospective study, we followed up a previously published cohort of patients with (n= 223) and without (n= 216) thiazide-induced hyponatraemia. RESULTS: A total of 61 osteoporotic fractures was recorded during a mean follow-up period of 82 months. Using univariate regression analysis, the hazard ratio of thiazide-induced hyponatraemia was 1.78 (95% confidence interval (CI), 1.05-3.03; P= 0.033). Cox proportional hazards regression analysis, however, showed that age, body mass index and diabetes mellitus were the only independent predictors of osteoporotic fractures. No association of a history of thiazide-induced hyponatraemia and risk of fracture was evident in the final model. CONCLUSION: Since a history of thiazide-induced hyponatraemia is associated with osteoporotic fracture in univariate but not multivariate analyses, an alternative explanation is that confounding factors of older age and low body mass index accounted for the apparently increased risk of osteoporotic fracture in patients with thiazide-induced hyponatraemia.


Subject(s)
Hyponatremia/chemically induced , Hyponatremia/epidemiology , Osteoporotic Fractures/epidemiology , Sodium Chloride Symporter Inhibitors/adverse effects , Aged , Aged, 80 and over , Cohort Studies , Female , Follow-Up Studies , Fractures, Bone/blood , Fractures, Bone/epidemiology , Humans , Hyponatremia/blood , Male , Middle Aged , Osteoporotic Fractures/blood , Retrospective Studies , Risk Factors , Sodium Chloride Symporter Inhibitors/blood
SELECTION OF CITATIONS
SEARCH DETAIL